Phesgo

Pertuzumab/trastuzumab/hyaluronidase, sold under the brand name Phesgo, is a fixed-dose combination medication to treat adults with HER2-positive breast cancer that has spread to other parts of the body, and for treatment of adults with early HER2-positive breast cancer.[3][4] It contains pertuzumab, trastuzumab, and hyaluronidase–zzxf.[3] It is injected under the skin via subcutaneous injection in the thigh.[3] In the Euro... [wikipedia]